Patent · US Expired

Process for the isolation of lovastatin

US7052886B2 · kind B2 · utility

1Cited by
7References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 2001
Grant dateMay 30, 2006
Priority date
Expiry dateSep 20, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D309/30
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The process for the preparation and isolation of the hypolipaemic active substance lovastatin in substantially pure form having a purity of at least 95% which comprises lactonizing the mevinolinic acid to lovastatin in a totally aqueous medium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.